Fil-Am med student leads important Alzheimer’s study

Fil-Am med student leads important Alzheimer’s study

09:47 AM September 16, 2020

Justin Bauzon, a third-year UNLV Medical School student is the lead author of an important Alzheimer’s study. UNLV NEWS CENTER

LAS VEGAS – A Filipino American third-year medical student has become the lead author of an important research article in the highly respected, peer-reviewed Alzheimer’s Research & Therapy journal, the University of Nevada, Las Vegas School of Medicine announced.

Justin Bauzon’s research team examines whether drugs used for one purpose can also be an effective treatment for the progressive and fatal Alzheimer’s brain disease.


Alzheimer’s has robbed more than 5 million Americans of memory, and the disease is now feared even more than cancer or heart disease.

Bauzon’s paper shows how many repurposed drugs are being tested in Alzheimer’s disease and the conditions for which they are already approved.


Trials for the repurposing of drugs are not unusual as it is also not unusual for one drug to be effective for more than one disease.

Gabapentin, for instance, was originally developed for treating epilepsy and is now an effective pain-killer. Sildenafil, originally developed for treating high blood pressure, is today more often used to treat erectile dysfunction.

Drugs created to combat one type of cancer have been found to be effective against other types.

“Millions of dollars can be shaved off by bypassing some early trials that drugs go through,” Bauzon told the UNLV News Center. There are 58 drugs now in various stages of clinical trials for repurposing as a treatment for Alzheimer’s.

“(Bauzon’s study) is an important contribution to understanding Alzheimer’s drug development and will encourage others to use the repurposing strategy, ultimately resulting in better treatments for patients,” said Dr. Jeffrey Cummings, the former medical director of the Cleveland Clinic Lou Ruvo Center for Brain Health in Las Vegas and now director of the Chambers-Grundy Center for Transformative Neuroscience in the UNLV department of brain health.

Dr. Dale Netski, the UNLV School of Medicine director of medical student research, called Bauzon’s first-author publication in a very competitive peer-reviewed journal ”an amazing accomplishment for a third-year medical student.”

Bauzon’s father is a family physician and his mother is a neonatal nurse who decided to concentrate on the raising of her children. The family immigrated to the U.S. from the Philippines in the ‘70s, moving to Las Vegas from California when Bauzon was 10.

Bauzon said his mother’s decision “to design an at-home after-school curriculum that involved science experiments and regular creative writing exercises” led to his appetite for learning.

Subscribe to our newsletters! Get updates right into your inbox

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.
Don't miss out on the latest news and information.
TAGS: Alzheimer’s drug trials, Alzheimer’s drugs, Alzheimer’s research, brain disease, Justin Bauzon, repurposing drugs for Alzheimer’s, UNLV School of Medicine
For feedback, complaints, or inquiries, contact us.

Subscribe to our newsletters!
Get Updates right into your inbox

By providing an email address. I agree to the Terms of Use and
acknowledge that I have read the Privacy Policy.

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.